Bloqueantes adrenérgicos y funcionalismo tiroideo

descriptionPublicationkeyboard_double_arrow_right Article 01 Jan 1973 Spain Spanish Publisher:Acadèmia de Ciències Mèdiques i de la Salut de Catalunya i de Balears

Authors: Cuenca Sala, Emili; Gibert Rahola, J.; García-Valdecasas, Francisco, 1910-2005;

handle: 2445/172038

Bloqueantes adrenérgicos y funcionalismo tiroideo

- Summary
- Subjects
- Metrics

Abstract

La participación del sistema adrenérgico en las manifestaciones clínicas del hipertiroidismo, ha sido señalada por diversos autores (GOETSCHE, 1918; PRIESTLY y cols., 1931; ROSENBLUM y cols., 1933; SAWYER y BROWN, 1935; McDONAL y cols., 1935; BARKER y cols., 1936; SCHNECKLOTH y cols., 1953; BREWSTER, 1956; WURTMAN y cols., 1963; GOLDSTEIN y KILLIP, 1965; HARRISON, 1967; MORI, 1968; WADA, 1968). La primera sugerencia se debe a GOETSCHE (1918 ). Este autor observó que los efectos cardíacos de la adrenalina, en pacientes hipertiroideos, estaban aumentados, mientras que, en otros procesos que cursan con taquicardia -ansiedad- el aumento era menor...

Country

Spain

Related Organizations

University of Barcelona
Spain

Keywords

Catecolamines, Catecholamines, Hipertiroïdisme, Hyperthyroidism

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average